A

Propranolol has become the first-line (drug-of-choice) therapy for complicated infantile hemangiomas, especially those that are ulcerated, with rapid healing and involution seen after treatment [Kim, 2011, PMID 21496551]. It is not effective for lymphangiomas, pyogenic granulomas, or capillary malformations, which are managed by other modalities.